DEF: Phreesia Announces 2026 Annual Meeting Details

Phreesia, Inc. invites stockholders to its 2026 Annual Meeting on June 24, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

Summary

• Phreesia, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on June 24, 2026, at 9:00 a.m. Eastern Time.
• Stockholders of record as of May 1, 2026, are eligible to vote.
• Key proposals include the election of two Class I directors, ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending January 31, 2027, and an advisory vote to approve executive compensation.
• The Board of Directors recommends voting FOR all three proposals.
• The meeting will be conducted online via a live audio webcast at www.virtualshareholdermeeting.com/PHR2026.
• Proxy materials were made available online on or about May 14, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as generally positive, reflecting standard corporate governance procedures and a company that has achieved significant financial improvements in the past fiscal year, though the CEO pay ratio warrants attention.

Positives

• The company is holding its annual meeting to ensure shareholder engagement and governance.
• The Board recommends favorable votes for director nominees, auditor ratification, and executive compensation, indicating confidence in current leadership and practices.
• The virtual meeting format offers accessibility to stockholders globally.
• The company highlights its commitment to responsible business practices, employee experience, and sustainability.
• Strong performance in fiscal year 2026, including revenue growth and a significant increase in net income and Adjusted EBITDA, is noted in the Compensation Discussion and Analysis.

Negatives

• The company's net income for fiscal year 2026 was $2.3 million, a significant improvement from a net loss of $58.5 million in fiscal year 2025, but still a relatively small profit compared to revenue.
• The CEO pay ratio is 108:1, indicating a substantial difference between CEO compensation and the median employee compensation.
• The company's 2023 PSUs did not meet performance targets and were not earned.

Risks

• The election of directors requires a plurality of votes, and while nominees are recommended, shareholder votes will determine outcomes.
• The company's business is subject to risks inherent in the healthcare technology and SaaS industries, including cybersecurity, data privacy, and regulatory changes.
• The compensation program, while performance-based, involves complex equity awards (PSUs) whose ultimate value depends on future market performance relative to the Russell 3000 index.
• The company's reliance on technology and digital infrastructure presents potential risks related to system failures or cyberattacks.

Future Outlook

The filing does not contain specific forward-looking financial guidance. However, the proposals for director elections and executive compensation approval, along with the ratification of the auditor, suggest a focus on continued operational stability and governance.

Management Comments

• "We believe that separating these roles is appropriate as it allows us to pursue strategic and operational objectives while maintaining effective oversight and objective evaluation of corporate performance."
• "Our Board believes that diversity in its membership should represent a diverse mix of skills, industry experience, backgrounds (including race, ethnicity and gender), ages and other unique characteristics."
• "At Phreesia, we are guided by our commitment to responsible business practices through a culture that promotes honest and ethical conduct, respects our employees and communities, and safeguards the information under our care."
• "Our executive compensation program is designed to drive and reward performance and align the compensation of our named executive officers with the long-term interests of our stockholders."

Industry Context

StockSavvy.ai notes that Phreesia's proxy statement reflects standard corporate governance practices for a publicly traded SaaS company in the healthcare technology sector. The focus on director elections, auditor ratification, and executive compensation is typical for annual meetings. The company's emphasis on a virtual meeting format aligns with its fully remote operational model.

Comparison to Industry Standards

• The company's compensation peer group includes companies like Fastly, PagerDuty, and EverCommerce, which are comparable SaaS and technology firms, indicating an effort to benchmark executive compensation against industry standards.
• The CEO pay ratio of 108:1 is within the range often seen in the technology sector, though specific comparisons would require data from direct competitors.
• The company's commitment to independent board committees (Audit, Compensation, Nominating & Governance) aligns with best practices for corporate governance in publicly traded companies.

Management Changes

Corporate Governance

Legal Proceedings

• One late Form 4 was filed for David Linetsky to report one transaction by his spouse that was not previously reported.

Related Party Transactions

• Phreesia recognized approximately $1.1 million in revenue from advertising placed by Jazz Pharmaceuticals plc, where director Mark Smith, M.D. also serves on the board.
• The spouse of David Linetsky, President of Network Solutions, is employed by Phreesia with a fiscal 2026 base salary of approximately $235,000, a variable cash bonus of approximately $17,083, and RSU awards of approximately $61,511. Compensation was determined according to standard practices.

Stakeholder Impact

• Shareholders: Will vote on director elections, auditor ratification, and executive compensation, influencing corporate governance and executive accountability.
• Employees: The company highlights its commitment to employee experience, wellness, and ethical conduct, with various recognitions for being a top workplace.
• Management: Executive compensation is tied to performance metrics, with a significant portion in equity, aligning their interests with shareholders.
• Auditors (KPMG LLP): Their appointment for the fiscal year ending January 31, 2027, is subject to shareholder ratification.

Next Steps

• Stockholders are encouraged to vote on the proposals before the Annual Meeting.
• The company will announce preliminary voting results at the Annual Meeting.
• Final voting results will be disclosed in a Current Report on Form 8-K filed with the SEC within four business days after the Annual Meeting.

Key Dates

Recommendation

The filing is a routine proxy statement for an annual meeting, detailing director nominations, auditor ratification, and executive compensation. While the company reported improved financial performance in FY2026, there are no significant new strategic initiatives or material changes that would warrant a strong buy or sell recommendation based solely on this document. The company's governance practices and compensation structures are standard for its industry. A 'hold' recommendation is appropriate pending further strategic or financial disclosures.

Keywords

Phreesia, Annual Meeting, Proxy Statement, Director Election, KPMG LLP, Executive Compensation, Stockholder Vote, Virtual Meeting, Corporate Governance, Fiscal Year 2026